Prospective Randomized Evaluation of Celeboxib Integrated Safety Versus Ibuprofen or Naproxen - PRECISION Trial Results

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time -0:00

0.5x
0.75x
1x, selected
1.25x
1.5x
1.75x
2x

Chapters

descriptions off, selected

captions settings, opens captions settings dialog
captions off, selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

TextColorTransparency

BackgroundColorTransparency

WindowColorTransparency

Font Size

Text Edge Style

Font Family

End of dialog window.

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

Prospective Randomized Evaluation of Celeboxib Integrated Safety Versus Ibuprofen or Naproxen - PRECISION Trial Results

By Cleveland Clinic Heart, Vascular and Thoracic Institute FEATURING Steven Nissen

0 views

January 19, 2017

Dr. Steven Nissen presents the findings and clinical implications from the PRECISION Trial, a long ...
read more ↘ term trial studying the cardiovascular effects and safety of celecoxib vs. two other non-steroidal anti-inflammatory drugs (NSAIDs) and . Read article at http://www.nejm.org/doi/full/10.1056/NEJMoa1611593#t=article
↖ read less

Comments 0